0000899243-19-005960.txt : 20190304
0000899243-19-005960.hdr.sgml : 20190304
20190304201209
ACCESSION NUMBER: 0000899243-19-005960
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190304
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lawton Alison Frances
CENTRAL INDEX KEY: 0001542650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38822
FILM NUMBER: 19656237
MAIL ADDRESS:
STREET 1: 39 ROBINSON ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02420
FORMER NAME:
FORMER CONFORMED NAME: LAWTON ALISON FRANCIS
DATE OF NAME CHANGE: 20120216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kaleido Biosciences, Inc.
CENTRAL INDEX KEY: 0001751299
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 617-674-9000
MAIL ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-04
0
0001751299
Kaleido Biosciences, Inc.
KLDO
0001542650
Lawton Alison Frances
C/O KALEIDO BIOSCIENCES, INC.
65 HAYDEN AVE.
LEXINGTON
MA
02421
1
1
0
0
See Remarks
Stock Option (Right to Buy)
15.00
2019-03-04
4
A
0
150000
0.00
A
2029-03-04
Common Stock
150000
150000
D
25% of this option shall vest on January 23, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.
President and Chief Executive Officer
/s/ Joshua T. Brumm, as Attorney-in-Fact
2019-03-04